[Position on blood collection and use of convalescent plasma as a treatment option in the outbreak of severe infections].
出版信息
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Nov;58(11-12):1371-7. doi: 10.1007/s00103-015-2256-9.
Abstract
摘要
相似文献
1
[Position on blood collection and use of convalescent plasma as a treatment option in the outbreak of severe infections].[关于在严重感染暴发时采集和使用康复期血浆作为一种治疗选择的立场]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Nov;58(11-12):1371-7. doi: 10.1007/s00103-015-2256-9.
2
Infectious diseases. Ebola survivors fight back in plasma studies.传染病。埃博拉幸存者在血浆研究中奋起反击。
Science. 2015 May 15;348(6236):742-3. doi: 10.1126/science.348.6236.742.
3
Treatment of Ebola virus infection with antibodies from reconvalescent donors.使用康复者捐献者的抗体治疗埃博拉病毒感染。
Emerg Infect Dis. 2015 Mar;21(3):521-3. doi: 10.3201/eid2103.141838.
4
Treatment-donation-stockpile dynamics in ebola convalescent blood transfusion therapy.埃博拉康复期血液输血治疗中的治疗-捐赠-储备动态
J Theor Biol. 2016 Mar 7;392:53-61. doi: 10.1016/j.jtbi.2015.11.031. Epub 2015 Dec 23.
5
Ebola virus convalescent blood products: where we are now and where we may need to go.埃博拉病毒康复期血液制品：我们目前的状况及可能的发展方向。
Transfus Apher Sci. 2014 Oct;51(2):120-5. doi: 10.1016/j.transci.2014.10.003.
6
[Determining donor eligibility and donor suitability of hemochromatosis marker carriers ].[确定血色素沉着症标志物携带者的供体资格和供体适宜性]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Nov;58(11-12):1349-50. doi: 10.1007/s00103-015-2250-2.
7
Managing Ebola: Lessons Learned from the SARS Epidemic.应对埃博拉：从非典疫情中汲取的教训
Anesth Analg. 2015 Sep;121(3):834-835. doi: 10.1213/ANE.0000000000000748.
8
Pathogen-reduced Ebola virus convalescent plasma: first steps towards standardization of manufacturing and quality control including assessment of Ebola-specific neutralizing antibodies.病原体灭活的埃博拉病毒康复期血浆：迈向制造标准化和质量控制的第一步，包括评估埃博拉特异性中和抗体。
Vox Sang. 2016 May;110(4):329-35. doi: 10.1111/vox.12376. Epub 2016 Jan 14.
9
The ongoing evolution of antibody-based treatments for Ebola virus infection.埃博拉病毒感染的抗体疗法的持续演变。
Immunotherapy. 2017 Mar;9(5):435-450. doi: 10.2217/imt-2017-0010.
10
Design and analysis considerations in the Ebola_Tx trial evaluating convalescent plasma in the treatment of Ebola virus disease in Guinea during the 2014-2015 outbreak.2014 - 2015年埃博拉疫情期间在几内亚进行的评估恢复期血浆治疗埃博拉病毒病的埃博拉治疗试验中的设计与分析考量
Clin Trials. 2016 Feb;13(1):13-21. doi: 10.1177/1740774515621056. Epub 2016 Jan 14.
引用本文的文献
1
Multistep screening and selection of COVID-19 convalescent plasma donors at the early stage of the SARS-CoV-2 pandemic: A retrospective analysis.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）大流行早期新冠康复者血浆捐献者的多步骤筛查与选择：一项回顾性分析
Health Sci Rep. 2022 Sep 13;5(5):e815. doi: 10.1002/hsr2.815. eCollection 2022 Sep.
2
Emergency Use of Convalescent Plasma: Perception of the Regulatory Framework from a Clinical Perspective.恢复期血浆的紧急使用：从临床角度看监管框架
Transfus Med Hemother. 2021 Nov 15;49(2):119-124. doi: 10.1159/000519841. eCollection 2022 Apr.
本文引用的文献
1
Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection.恢复期血浆治疗可降低严重大流行流感 A（H1N1）2009 病毒感染患者的死亡率。
Clin Infect Dis. 2011 Feb 15;52(4):447-56. doi: 10.1093/cid/ciq106. Epub 2011 Jan 19.
2
Metagenomic sequencing for virus identification in a public-health setting.在公共卫生环境中进行病毒鉴定的宏基因组测序。
J Gen Virol. 2010 Nov;91(Pt 11):2846-56. doi: 10.1099/vir.0.024612-0. Epub 2010 Jul 21.
3
Practical limitations of convalescent plasma collection: a case scenario in pandemic preparation for influenza A (H1N1) infection.恢复期血浆采集的实际限制：甲型流感（H1N1）大流行准备期间的案例分析。
Transfusion. 2010 Sep;50(9):1967-71. doi: 10.1111/j.1537-2995.2010.02651.x.
4
Treatment with convalescent plasma for influenza A (H5N1) infection.用康复期血浆治疗甲型H5N1流感感染。
N Engl J Med. 2007 Oct 4;357(14):1450-1. doi: 10.1056/NEJMc070359.
5
Rapid identification of emerging infectious agents using PCR and electrospray ionization mass spectrometry.利用聚合酶链式反应（PCR）和电喷雾电离质谱法快速鉴定新出现的传染病病原体。
Ann N Y Acad Sci. 2007 Apr;1102(1):109-20. doi: 10.1196/annals.1408.008.
6
Viral metagenomics.病毒宏基因组学
Rev Med Virol. 2007 Mar-Apr;17(2):115-31. doi: 10.1002/rmv.532.
7
Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?荟萃分析：用于西班牙流感肺炎的恢复期血液制品：未来治疗H5N1的方法？
Ann Intern Med. 2006 Oct 17;145(8):599-609. doi: 10.7326/0003-4819-145-8-200610170-00139. Epub 2006 Aug 29.
8
Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature.静脉注射免疫球蛋白的当前应用情况及其背后的原理：麻省总医院的数据及文献综述
Transfusion. 2006 May;46(5):741-53. doi: 10.1111/j.1537-2995.2006.00792.x.
9
Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital.台湾一家医院医护人员使用恢复期血浆治疗严重急性呼吸综合征的经验。
J Antimicrob Chemother. 2005 Nov;56(5):919-22. doi: 10.1093/jac/dki346. Epub 2005 Sep 23.
10
Use of convalescent plasma therapy in SARS patients in Hong Kong.香港严重急性呼吸系统综合症患者康复期血浆疗法的应用。
Eur J Clin Microbiol Infect Dis. 2005 Jan;24(1):44-6. doi: 10.1007/s10096-004-1271-9.
Zotero 插件